Clinically localized ovarian cancer: Progress in management: Postgraduate Medicine: Vol 77, No 4

Views

CrossRef citations to date

Altmetric

Preview

Ovarian cancer is the leading killer among gynecologic malignancies, and its incidence appears to be increasing in the United States. Nevertheless, significant medical advances offer hope for earlier diagnosis and better treatment and thus an improved survival rate. Drs Piver and Patsner examine the progress that has been made in the past ten years and the prospects for the future.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinically localized ovarian cancer

Progress in management

Information for

Open access

Opportunities

Help and information

Clinically localized ovarian cancer

Progress in management

Preview

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature